[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.211.117. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
March 26, 2007

Can Aspirin Keep Mortality at Bay?

Arch Intern Med. 2007;167(6):535-536. doi:10.1001/archinte.167.6.535

In this issue of the ARCHIVES, Chan et al1 report a strong association between aspirin use and reduced cardiovascular mortality in middle-aged and older women. This analysis of almost 80 000 women is derived from the Nurses' Health Study (NHS), a well-known and well-conducted observational research effort that has been ongoing for about 30 years. Readers may recall another study on a similar topic published in 2005, the Women's Health Study (WHS).2 That trial, carried out during more than 11 years in almost 40 000 women, reported that aspirin therapy had no effect on cardiovascular or other mortality. Which of these mega-studies is right? Both somehow? Neither?

First Page Preview View Large
First page PDF preview
First page PDF preview
×